F & N/ SG1T58930911 /
2024-05-08 12:00:00 AM | Chg. 0.000 | Volume | Bid10:35:08 AM | Ask11:06:00 AM | High | Low |
---|---|---|---|---|---|---|
1.020SGD | 0.00% | 61,200 Turnover: 62,174 |
1.020Bid Size: - | 1.030Ask Size: - | 1.020 | 1.010 |
GlobeNewswire
10:00 AM
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Inv...
GlobeNewswire
10:00 AM
EQIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Equinix, Inc. Investors with S...
GlobeNewswire
10:00 AM
ASTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AST SpaceMobile, Inc. Investor...
GlobeNewswire
10:00 AM
LNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lincoln National Corporation In...
GlobeNewswire
10:00 AM
CMP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Minerals International,...
GlobeNewswire
10:00 AM
ADSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Autodesk, Inc. Investors with ...
GlobeNewswire
8:35 AM
Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...
GlobeNewswire
8:30 AM
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024